Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.

× No keyword cloud information.

44 in total

1. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.

Authors: U H Ochs; S H Chen; H D Ochs; W R Osborne; C R Scott
Journal: J Immunol Date: 1979-06 Impact factor: 5.422

2. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

Authors: D A Carson; J Kaye; J E Seegmiller
Journal: Proc Natl Acad Sci U S A Date: 1977-12 Impact factor: 11.205

3. Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition.

Authors: C A Koller; B S Mitchell; M R Grever; E Mejias; L Malspeis; E N Metz
Journal: Cancer Treat Rep Date: 1979 Nov-Dec

4. In vitro and in vivo effect of deoxycoformycin in human T cell leukemia.

Authors: A L Yu; F H Kung; B Bakay; W L Nyhan
Journal: Adv Exp Med Biol Date: 1979 Impact factor: 2.622

5. Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.

Authors: M S Hershfield; J E Fetter; W C Small; A S Bagnara; S R Williams; B Ullman; D W Martin; D B Wasson; D A Carson
Journal: J Biol Chem Date: 1982-06-10 Impact factor: 5.157

6. Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors: M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal: J Biol Chem Date: 1978-03-10 Impact factor: 5.157

7. Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors: E W Gelfand; J J Lee; H M Dosch
Journal: Proc Natl Acad Sci U S A Date: 1979-04 Impact factor: 11.205

8. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia.

Authors: D G Poplack; S E Sallan; G Rivera; J Holcenberg; S B Murphy; J Blatt; J M Lipton; P Venner; D L Glaubiger; R Ungerleider; D Johns
Journal: Cancer Res Date: 1981-09 Impact factor: 12.701

9. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.

Authors: A S Bagnara; M S Hershfield
Journal: Proc Natl Acad Sci U S A Date: 1982-04 Impact factor: 11.205

10. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors: D A Carson; D B Wasson; E Lakow; N Kamatani
Journal: Proc Natl Acad Sci U S A Date: 1982-06 Impact factor: 11.205

3 in total

Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.